Results 1 to 10 of about 364,170 (283)

Uptake of the hepatitis B vaccine among brothel-based female sex workers in Kampala, Uganda [PDF]

BMC Public Health
Background Hepatitis B is a significant health problem worldwide, particularly among high-risk groups such as female sex workers (FSWs). In Uganda, it is highly recommended that FSWs receive the hepatitis B vaccine.
Joana Nakiggala, Mathias Lwenge, Doreen Nakalembe, Bridget Nagawa Tamale, Aisha Nalugya, Jovan Galiwango, Junior Mike Wejuli, Kenneth Tebandeke, John Bosco Isunju, Richard K. Mugambe, Tonny Ssekamatte   +10 more
doaj   +2 more sources

Hepatitis B Vaccine: Four Decades on [PDF]

Vaccines
Hepatitis B virus is a substantial contributor to cirrhosis and hepatocellular carcinoma (HCC) globally. Vaccination is the most effective method for prevention of hepatitis B and its associated morbidity and mortality, and the only method to prevent ...
Maria Mironova, Marc G. Ghany
doaj   +2 more sources

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review [PDF]

Human Vaccines & Immunotherapeutics
Hepatitis B vaccination is the most effective means of interrupting HBV transmission. Although the hepatitis B vaccine is very effective and safe, adverse events following immunization do occur and need to be reported so that problems can be identified ...
Xiaoying Gong, Quanjun Fang, Jianyue Zhong, Canjie Zheng, Zhiying Yin   +4 more
doaj   +2 more sources

Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping Review [PDF]

Pathogens
Background: The advent of the hepatitis B vaccine has achieved tremendous success in eradicating and reducing the burden of hepatitis B infection, which is the main culprit for hepatocellular carcinoma—one of the most fatal malignancies globally ...
Nura Bello, Shuaibu A. Hudu, Ahmed S. Alshrari, Mustapha U. Imam, Abdulgafar O. Jimoh   +4 more
doaj   +2 more sources

Time interval distribution of hepatitis B vaccine immunization among infants in China from 2017 to 2021 [PDF]

Human Vaccines & Immunotherapeutics
Infant hepatitis B vaccine coverage in China is high, with over 95% of infants immunized; however, high vaccine coverage can often mask low timeliness.
Sihui Zhang, Xiaoling Tian, Li Wang, Ming Liu, Chao Wang, Tianshuo Zhao, Xianming Cai, Xiyu Zhang, Mingting Wang, Juan Du, Yaqiong Liu, Qingbin Lu, Jiang Wu, Ninghua Huang, Fuqiang Cui   +14 more
doaj   +2 more sources

Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study [PDF]

Journal of Tropical Medicine
Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality.
Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Sa’adatu Haruna Shinkafi, Albashir Tahir, Ahmed Subeh Alshrari, Muhammad Tukur Umar, Abdulmajeed Yunusa, Nura Bello, Nura Abubakar   +8 more
doaj   +2 more sources

A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors [PDF]

Vaccines
Hepatitis B virus (HBV) infection remains a significant global health concern worldwide, contributing to high rates of mortality and morbidity, including chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC).
Albashir Tahir, Sa’adatu Haruna Shinkafi, Ahmed Subeh Alshrari, Abdulmajeed Yunusa, Muhammad Tukur Umar, Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh   +6 more
doaj   +2 more sources

Long-term hepatitis B vaccine immunity in Ethiopian children that received a pentavalent vaccine series: a retrospective cohort study [PDF]

International Journal of Infectious Diseases
Introduction: Chronic hepatitis B affects close to 300 million people globally with 1.5 million new infections per year. It causes the highest numbers of cirrhosis and liver cancer diagnoses each year. In children, perinatal transmission and contact with
Dr Tinsae Alemayehu, Dr Million Dechassa Daba, Dr Danilo Buonsenso   +2 more
doaj   +2 more sources

Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B

Vaccines, 2022
Nasvac (HeberNasvac®) is a novel therapeutic vaccine for chronic hepatitis B (CHB). This product is a formulation of the core (HBcAg) and surface (HBsAg) antigens of the hepatitis B virus (HBV), administered by nasal and subcutaneous routes, in a ...
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar   +2 more
doaj   +1 more source

Knowledge and associated factors for the uptake of hepatitis B vaccine among nonmedical undergraduate students in a private university in Ekiti State, Nigeria

Nigerian Journal of Medicine, 2022
Background: Hepatitis B is a life-threatening viral infection that causes acute and chronic diseases of the liver. Hepatitis B infection is endemic in Nigeria with a national pooled prevalence rate of 9.5%.
Olusegun Elijah Elegbede, Ayodele Kamal Alabi, Taiye Adeyanju Alao, Taofeek Adedayo Sanni   +3 more
doaj   +1 more source